Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice

• Published in: The Journal of pharmacology and experimental therapeutics Vol. 232; no. 3; p. 857
• Main Authors: Corcoran, G B, Todd, E L, Racz, W J, Hughes, H, Smith, C V, Mitchell, J R
• Format: Journal Article
• Language: English
• Published: United States 01-03-1985
• Subjects: Acetaminophen - metabolism; Acetaminophen - poisoning; Acetylcysteine - pharmacology; Animals; Bile - metabolism; Chemical and Drug Induced Liver Injury - pathology; Chemical and Drug Induced Liver Injury - prevention & control; Chromatography, High Pressure Liquid; Glutathione - metabolism; Inactivation, Metabolic; Male; Mass Spectrometry; Metabolic Clearance Rate - drug effects; Mice; Mice, Inbred ICR
• ISSN: 0022-3565

N-acetylcysteine is the drug of choice for the treatment of acetaminophen poisoning, yet the mechanism of protection in vivo is unknown. Prevention of liver injury could result from decreased production of the toxic intermediate(s), from increased capacity to detoxify the toxic intermediate(s) or from increased ability of the tissue to withstand or even repair the molecular damage caused by the toxic species. Treatment of mice with N-acetylcysteine (1200 mg/kg p.o.) was found to prevent the hepatic damage caused by 1000 mg/kg p.o. of acetaminophen. Possible mechanisms for this hepatoprotective effect were examined by measurement at different time points of acetaminophen and its metabolites in plasma, urine, bile and whole-body homogenates and by evaluation of the changes in these parameters caused by treatment with N-acetylcysteine. A high-pressure liquid chromatographic method was developed to measure the majority urinary metabolites of acetaminophen and was validated by desorption chemical ionization mass spectral analysis of individual metabolites. Minimal differences in the concentration of unchanged acetaminophen and metabolites in whole-body homogenates at 4, 6 and 24 hr postdose were noted for N-acetylcysteine-treated vs. vehicle-treated mice. These results are incompatible with a decreased formation of the toxic species secondary to delayed acetaminophen absorption from the gastrointestinal tract or with an increased clearance of acetaminophen via nontoxic pathways such as sulfation as plausible mechanisms for the observed hepatoprotection.